Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Sweden Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20051
20074
20081
20091
20101
20113
20122
20133
20143
20171
20183
20191
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated8
Active, not recruiting5
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Sanofi4
Pfizer3
AbbVie2
AstraZeneca2
Cell Genesys2
European Organisation for Research and Treatment of Cancer - EORTC2
Novartis Pharmaceuticals2
Amgen1
Astellas Pharma Europe Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis35
Neoplasms9
Breast Neoplasms6
Prostatic Neoplasms6
Colorectal Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Melanoma4
Pancreatic Neoplasms3
Skin Neoplasms3
Carcinoma, Renal Cell2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.